Brief: Helius Medical Announces Health Canada Authorization To Market Portable Neuromodulation Stimulator Device For Treatment Of Gait Deficit Due To Mild And Moderate Symptoms From Stroke
09/03/2023 12:20
March 9 (Reuters) - Helius Medical Technologies Inc
HSDT.O :
* HELIUS MEDICAL TECHNOLOGIES ANNOUNCES AUTHORIZATION FROM
HEALTH
CANADA TO MARKET PORTABLE NEUROMODULATION STIMULATOR (PONS®)
DEVICE FOR THE TREATMENT OF GAIT DEFICIT DUE TO MILD AND
MODERATE SYMPTOMS FROM STROKE
Source text for Eikon: ID:nGNX2q0ClC
Further company coverage: HSDT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Solana
See all newsSolana Co reports results for the quarter ended June 30 - Earnings Summary
Solana Co Q2 net loss widens on higher operating expenses
Solana Co expected to post a loss of 2 cents a share - Earnings Preview
Solana Co expected to post a loss of 2 cents a share - Earnings Preview
Brief: Solana Partners With Alatau City For Digital Asset Infrastructure And Blockchain Adoption In Central Asia